Filing Details

Accession Number:
0001209191-16-149852
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-14 17:49:51
Reporting Period:
2016-11-09
Filing Date:
2016-11-14
Accepted Time:
2016-11-14 17:49:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1466562 A Justin Renz C/O Karyopharm Therapeutics Inc.
85 Wells Avenue
Newton MA 02459
Evp, Cfo & Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-11-09 4,342 $8.19 19,173 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
  2. The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 8, 2016 and November 9, 2016 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees.